AL
ESRX

Aspiriant LLC’s Express Scripts Holding Company ESRX Stock Holding History

Aspiriant LLC’s Portfolio ESRX Stock Details ESRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,414
Closed -$414K – 258
2018
Q3 		$414K Sell
4,414
-1,620
-27% -$138K 0.04% 168
2018
Q2 		$466K Sell
6,034
-1,207
-17% -$90.6K 0.04% 163
2018
Q1 		$500K Buy
+7,241
New +$552K 0.04% 153
2017
Q4 		– Sell
-11,465
Closed -$726K – 201
2017
Q3 		$726K Sell
11,465
-1,537
-12% -$95.5K 0.06% 125
2017
Q2 		$830K Sell
13,002
-1,739
-12% -$109K 0.07% 120
2017
Q1 		$971K Sell
14,741
-1,105
-7% -$76K 0.08% 116
2016
Q4 		$1.09M Sell
15,846
-2,495
-14% -$179K 0.1% 105
2016
Q3 		$1.29M Sell
18,341
-3,366
-16% -$252K 0.13% 91
2016
Q2 		$1.93M Buy
21,707
+480
+2% +$35.3K 0.18% 74
2016
Q1 		$1.46M Buy
+21,227
New +$1.53M 0.14% 85

Other funds holding ESRX

SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
BSPF
British Steel Pension Fund London, United Kingdom $410M AUM 11.96% 1-Year Est. Return
MYAM
Meiji Yasuda Asset Management Tokyo, Japan $2B AUM 22.52% 1-Year Est. Return
AWM
Alterna Wealth Management Houston, Texas $174M AUM 15.45% 1-Year Est. Return
W
Wealthquest Cincinnati, Ohio $1.41B AUM 14.87% 1-Year Est. Return
ACA
Atlas Capital Advisors Jackson, Wyoming $875M AUM
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
SBL
Sargent Bickham Lagudis Boulder, Colorado $1.22B AUM 14.94% 1-Year Est. Return

Aspiriant LLC's ESRX Position: Q4 2018 in Review

Aspiriant LLC sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 4,414 shares — an estimated $414K sold.

Aspiriant LLC first reported a position in ESRX in Q1 2016 and held it in 10 quarters. The position peaked at $1.93M in Q2 2016. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Aspiriant LLC reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Aspiriant LLC sold 4,414 Express Scripts Holding Company shares in Q4 2018, an estimated $414K.
  • Aspiriant LLC first reported a position in Express Scripts Holding Company in Q1 2016 and held it in 10 quarters.
  • Aspiriant LLC's Express Scripts Holding Company position peaked at $1.93M in Q2 2016.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Aspiriant LLC's 13F filing for Q4 2018, filed 4 Feb 2019.